American Thoracic Society, Inc. Parent
We Help the World Breathe
Learn how to support this organization
American Thoracic Society, Inc.
EIN: 06-1548706
as of September 2024
as of September 09, 2024
Mission
The American Thoracic Society (ATS) is a non-profit, international, professional and scientific society. It's mission is to accelerate global innovation in the advancement of respiratory health through multidisciplinary collaboration, education, and advocacy.
Ruling year
1999
Chief Executive Officer
Ms. Karen J. Collishaw MPP, CAE
Main address
25 Broadway, 4th Floor
New York, NY 10004 USA
EIN
06-1548706
Respiratory system diseases
Air quality
Tuberculosis
Palliative care
Lung cancer
Population served
People with diseases and illnesses
Ethnic and racial groups
Academics
NTEE code
Professional Societies, Associations (H03)
Lung (G45)
Professional Societies & Associations (C03)
IRS subsection
501(c)(3) Public Charity
IRS filing requirement
This organization is required to file an IRS Form 990 or 990-EZ.
Tax forms
Communication
Affiliations
Programs and results
Reports and documents
Download annual reportsWhat we aim to solve
We Help the World Breathe.
Our programs
What are the organization's current programs, how do they measure success, and who do the programs serve?
ATS Research Program
The American Thoracic Society and its Research Program are improving respiratory health worldwide by supporting young investigators in pulmonary, critical care, and sleep medicine. The ATS Research Program bolsters new investigators as they strive to launch independent research careers dedicated to innovation in patient care.
Since 2004, the Research Program has awarded $24 million in research grants to 330+ investigators who have gone on to secure more than $$880 million in NIH funding. That's a return on investment of $45 per dollar awarded.
Research has led to breathtaking advances in medicine. But there is much more to be learned, especially in pulmonary, critical care, and sleep medicine.
By providing research grants to promising young investigators, the ATS Research Program launches careers dedicated to advancing scientific discovery—and better patient care.
For more on the impact of our ATS Research Program: https://www.atsjournals.org/doi/full/10.1164/rccm.202402-0348
ATS International Conference
The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals from more than 100 countries choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. It is truly where today’s science meets tomorrow’s care.
Visit us at conference.thoracic.org to learn more.
ATS MECOR Program
The Methods in Epidemiologic, Clinical, and Operations Research (MECOR) Program has served as a pioneering initiative dedicated to advancing research skills in pulmonary, critical care, and sleep medicine globally. The MECOR Program thrives through partnerships across continents – from Africa to Asia, Latin America to the Mediterranean. Join us in this collaborative effort, bringing together diverse perspectives to tackle lung health challenges worldwide. Since 1994, MECOR has been committed to building medical research capacity in low- and middle-income countries, boasting a network of over 2,500 alumni around the world.
Full information and schedule can be seen on our website: https://site.thoracic.org/learning/mecor-global-health
ATS International Scholars Poster Colloquium
The ATS International Scholars Poster Colloquium is held annually in advance of the ATS International Conference. Showcasing the talented trainees who have earned recognition through the International Trainee Scholarship, this event acknowledges and celebrates the exceptional abstract submissions received from trainees worldwide. The 2024 Colloquium offered a unique opportunity for early-career investigators hailing from 31 countries to connect and engage with some of the brightest and most promising fields of respiratory health, as well as members of the ATS International Health Committee and Executive Committee.
We had more than 1,400 applications for this program for 2024 that we were unable to fund from North America (Canada, Panama and Mexico - 260), South America (70), Europe (420), Asia (526), Africa (26), Middle East (41) and Oceania (66).
Official ATS Documents
Official ATS Documents include clinical practice guidelines, clinical statements, policy statements, research statements, technical standards, and workshop reports, many of which are developed collaboratively with other professional societies. Most are published in the American Journal of Respiratory and Critical Care Medicine, one of our four peer-reviewed journals.
* Clinical practice guidelines make recommendations for patient care. The recommendations are based upon a systematic review and then formulated and graded using the GRADE approach.
* Clinical statements make recommendations for patient care, which are based upon a pragmatic evidence synthesis.
* Policy and research statements present the views of the ATS on issues related to public policy or research policy, respectively.
* Technical statements describe how to perform a test or procedure and describe the underlying evidence.
*Workshop reports describe conferences and workshops sponsored by the ATS.
American Journal of Respiratory and Critical Care Medicine
The American Journal of Respiratory and Critical Care Medicine (AJRCCM) publishes the most innovative research, highest quality reviews, clinical trials, guidelines, and statements in pulmonary, critical care, and sleep-related fields.
Known in the field as "the blue journal", AJRCCM is one of the most preeminent journals in pulmonary medicine. The first issue was published in 1917.
* Editorial Board: https://www.atsjournals.org/page/ajrccm/meet_the_editors
* Impact Factor: 19.3
* 5-year Impact Factor: 15.583
* Eigenfactor score: 0.08631
* Article Influence score: 7.251
* Google Scholar rank: 1st in pulmonology
* Google Scholar h5-index: 112
Time from Acceptance to Publication: Officially accepted articles are posted within 48 hours; print versions are published within 4 months
Time to First Decision: ~ 5 weeks for manuscripts sent out to peer review
American Journal of Respiratory Cell and Molecular Biology
The American Journal of Respiratory Cell and Molecular Biology (AJRCMB) publishes the most significant and original observations in the area of respiratory and lung cell biology, including cellular, biochemical, molecular, developmental, genetic, and immunologic studies in health and in acute and chronic disorders related to the respiratory system and sleep.
Known as "the red journal", AJRCMB was developed to address the shift in modern pulmonary science to lung cell and molecular biology The first issue was published in 1989.
* Meet the Editors: https://www.atsjournals.org
* Impact Factor: 5.9
* 5-year Impact Factor: 6.176
* Eigenfactor score: 0.01505
* Article Influence score: 2.053
* Google Scholar rank: 14th in pulmonology
* Google Scholar h5-index: 45
Time from Acceptance to Publication: Officially accepted articles are posted online within 48 hours; final versions are published within 3 months
Time to First Decision: ~ 4 weeks for manuscripts sent out to peer review
Annals ATS
The Annals of the American Thoracic Society (Annals ATS) publishes clinical trials, original research, ATS documents, systematic reviews, and case conferences in clinical, epidemiological, and health services research related to adult and pediatric pulmonary, respiratory, critical care medicine, sleep, and population health.
Annals ATS meets the needs and interests of clinicians. The first issue was published in 2004.
* Meet the Editors: https://www.atsjournals.org/page/AnnalsATS/meet_the_editors
* Impact Factor: 6.8
* 5-Year Impact Factor: 6.897
* Eigenfactor Score: 0.02883
* Article Influencer Score: 2.639
* Google Scholar rank: 7th in pulmonology
* Google Scholar h5-index: 57
Time to first decision: 16 days; 31 days excluding direct rejects
Time from Acceptance to Publication: Officially accepted articles are posted online within 48 hours; final versions are published within 4 months
Time to First Decision: ~ 6 weeks for manuscripts sent out to peer review
ATS Scholar
ATS Scholar is an open-access online journal publishing blind peer-reviewed health professions education manuscripts relevant to the fields of pulmonary, critical care, and sleep medicine, including those related to the teaching of common clinical topics, the training of healthcare providers and scientists, and educational research.
ATS Scholar was established to support the growing need of our members focused on medical education and training of the next generation. The first issue was published in 2020.
* Meet the Editors: https://www.atsjournals.org/journal/ats-scholar/editors
Where we work
Photos
Videos
Our results
How does this organization measure their results? It's a hard question but an important one.
Total number of organization members
This metric is no longer tracked.Totals By Year
Type of Metric
Output - describing our activities and reach
Direction of Success
Holding steady
Context Notes
ATS membership data show minor fluctuations over the years with a peak in 2020 attributed to the pandemic.
Total number of new organization members
This metric is no longer tracked.Totals By Year
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Context Notes
New ATS members are trending up annually overall with a noticeable peak in 2020 and a drop in 2021, attributable to the pandemic.
Number of conference attendees
This metric is no longer tracked.Totals By Year
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Context Notes
The ATS International Conference attendance numbers are verified annually by an external, third-party audit. Due to COVID-19, this meeting was not held in person in 2020 or 2021.
Total dollar amount of grants awarded
This metric is no longer tracked.Totals By Year
Population(s) Served
Researchers
Related Program
ATS Research Program
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Context Notes
ROI $45/$1 details in published manuscript "The ATS Research Program: Twenty Years of Driving Discovery in Respiratory Medicine"; visit https://www.atsjournals.org/doi/full/10.1164/rccm.202402-0348ED
Total number of grants awarded
This metric is no longer tracked.Totals By Year
Population(s) Served
Researchers
Related Program
ATS Research Program
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Context Notes
COVID impacted our program as our members are on the front lines of pulmonary and critical care. We are offering 13 grants for the 2024 cycle.
Number of research or policy analysis products developed, e.g., reports, briefs
This metric is no longer tracked.Totals By Year
Related Program
Official ATS Documents
Type of Metric
Output - describing our activities and reach
Direction of Success
Holding steady
Context Notes
Official ATS documents include treatment guidelines, policy statements, workshop reports More info: https://site.thoracic.org/clinicians-researchers/clinical-practice-guidelines-statements-reports
Our Sustainable Development Goals
Learn more about Sustainable Development Goals.
Goals & Strategy
Reports and documents
Download strategic planLearn about the organization's key goals, strategies, capabilities, and progress.
Charting impact
Four powerful questions that require reflection about what really matters - results.
What is the organization aiming to accomplish?
The ATS Strategic Framework is grounded in our goal to strengthen and expand the pulmonary, critical care communities through four pillars:
* Leading Scientific Discovery
* Transforming Patient Care
* Impacting Global Health
* Advancing Professional Development
We aim to have a sustainable organization, where every individual feels valued, respected and an integral part of our shared mission.
What are the organization's key strategies for making this happen?
Key areas of member focus include developing clinical practice guidelines, hosting the annual International Conference, publishing four peer-reviewed journals, advocating for improved respiratory health globally, and developing an array of patient education and career development resources.
What are the organization's capabilities for doing this?
As the world's leading medical society, we are dedicated to accelerating the advancement of global respiratory health through multidisciplinary collaboration, education, and advocacy. Core activities of the Society’s more than 16,000 members are focused on leading scientific discoveries, advancing professional development, impacting global health, and transforming patient care.
The ATS launched the Health Equity and Diversity Fund which supports programmatic activities and initiatives throughout the ATS organization related to promoting health equity and inclusion, including expanding our ATS Diversity Fellowships, funding research in at-risk communities, and establishing partnerships to increase the number of clinicians, researchers and scientists who are persons of color.
Our DC Office advocates for US regulatory policy to advance respiratory health for our patients and our members. Areas of focus include increased federal funding for research and the significant health and economic benefits that lung research yields, clean air regulations, tobacco control, access to liquid oxygen for patients who need it, as well as environmental and occupational health.
The ATS Public Advisory Roundtable (PAR) is a partnership with organizations representing persons affected by respiratory diseases, sleep-related conditions, or related critical illnesses. Together, we collaborate to advance shared educational, research, patient care and advocacy goals. Members serve on most ATS committees, bringing the patient voice to everything we do.
What have they accomplished so far and what's next?
From January 2020 to December 2023, the ATS published 69 official documents, including many clinical practice guidelines. Implementation of published guidelines is key to improving patient care.
The ATS Health Equity and Diversity Committee (HEDC) undertook several key ongoing initiatives throughout 2022 including leading and encouraging society-wide projects, symposia and publications addressing health equity. The HEDC also completed the second year of its mentoring program for those under-represented in medicine (URM) and in May 2024 onboarded a third cohort of mentees.
The ATS has been urging the Environmental Protection Agency to act on air pollution and climate change. We urged the EPA to issue more protective National Ambient Air Quality Standards for particulate matter and ozone pollution. The ATS has also advanced climate change science by contributing to the research supporting the improved social cost of carbon estimates, and the annual "Health of the Air" report.
Clean Air Act Cases Where ATS filed an Amicus brief
* White Stallion Energy Center v EPA (2013 – Mercury Air Toxics rule)
* West Virginia v EPA (2016 – Obama Clean Power Plan)
* American Lung Association v EPA (2020 Trump Affordable Clean Energy rule)
* Union of Concern Scientist v National Highway Traffic Safety Administration – round 1 (2020 CA GHG vehicle tailpipe emissions standards)
* Competitive Enterprise Institute v National Highway Traffic Safety Administration (2021 - round 2 national GHG vehicle tailpipe emissions standards)
* West Virginia v EPA (round 2 – US Supreme Court Case – EPA authority to regulate carbon)
In 2023, the ATS Public Advisory Roundtable published "Patient Voices 12: Mental and Emotional Health of Patients and Families", featuring patient insights in their own words. If you'd like a copy, please email [email protected] with your request.
How we listen
Seeking feedback from people served makes programs more responsive and effective. Here’s how this organization is listening.
-
How is your organization using feedback from the people you serve?
-
Which of the following feedback practices does your organization routinely carry out?
-
What challenges does the organization face when collecting feedback?
Financials
Financial documents
Download audited financialsRevenue vs. expenses: breakdown
Liquidity in 2022 info
1.36
Months of cash in 2022 info
5.8
Fringe rate in 2022 info
27%
Funding sources info
Assets & liabilities info
Financial data
American Thoracic Society, Inc.
Revenue & expensesFiscal Year: Jan 01 - Dec 31
American Thoracic Society, Inc.
Balance sheetFiscal Year: Jan 01 - Dec 31
The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.
Fiscal Year: Jan 01 - Dec 31
This snapshot of American Thoracic Society, Inc.’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.
Created in partnership with
Business model indicators
| Profitability info | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Unrestricted surplus (deficit) before depreciation | -$2,507,074 | $550,467 | -$1,664,710 | $206,473 | $7,636,412 |
| As % of expenses | -7.0% | 1.6% | -6.5% | 0.8% | 22.3% |
| Unrestricted surplus (deficit) after depreciation | -$2,733,368 | $310,128 | -$2,016,714 | -$335,619 | $7,282,078 |
| As % of expenses | -7.6% | 0.9% | -7.8% | -1.3% | 21.1% |
| Revenue composition info | |||||
|---|---|---|---|---|---|
| Total revenue (unrestricted & restricted) | $35,144,639 | $32,672,765 | $30,986,777 | $21,360,238 | $43,866,677 |
| Total revenue, % change over prior year | 5.6% | -7.0% | -5.2% | -31.1% | 105.4% |
| Program services revenue | 82.9% | 87.5% | 39.7% | 76.0% | 59.5% |
| Membership dues | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Investment income | 1.0% | 1.5% | 1.5% | 1.9% | 1.1% |
| Government grants | 1.1% | 0.0% | 0.0% | 0.2% | 10.9% |
| All other grants and contributions | 11.0% | 5.3% | 39.4% | 13.6% | 9.5% |
| Other revenue | 4.1% | 5.7% | 19.4% | 8.4% | 19.0% |
| Expense composition info | |||||
|---|---|---|---|---|---|
| Total expenses before depreciation | $35,790,361 | $34,527,207 | $25,523,470 | $24,656,650 | $34,184,829 |
| Total expenses, % change over prior year | 14.9% | -3.5% | -26.1% | -3.4% | 38.6% |
| Personnel | 30.7% | 36.4% | 51.2% | 52.6% | 40.1% |
| Professional fees | 26.3% | 25.6% | 22.1% | 19.4% | 29.7% |
| Occupancy | 3.3% | 4.4% | 7.3% | 7.0% | 5.5% |
| Interest | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Pass-through | 7.7% | 4.8% | 2.2% | 6.5% | 4.6% |
| All other expenses | 32.0% | 28.7% | 17.2% | 14.6% | 20.2% |
| Full cost components (estimated) info | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total expenses (after depreciation) | $36,016,655 | $34,767,546 | $25,875,474 | $25,198,742 | $34,539,163 |
| One month of savings | $2,982,530 | $2,877,267 | $2,126,956 | $2,054,721 | $2,848,736 |
| Debt principal payment | $0 | $0 | $0 | $0 | $4,319,008 |
| Fixed asset additions | $368,500 | $1,668,848 | $0 | $0 | $0 |
| Total full costs (estimated) | $39,367,685 | $39,313,661 | $28,002,430 | $27,253,463 | $41,706,907 |
Capital structure indicators
| Liquidity info | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Months of cash | 3.8 | 2.5 | 6.0 | 8.0 | 5.8 |
| Months of cash and investments | 10.4 | 10.6 | 18.4 | 20.8 | 15.4 |
| Months of estimated liquid unrestricted net assets | 7.8 | 7.7 | 9.5 | 9.7 | 10.3 |
| Balance sheet composition info | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Cash | $11,252,876 | $7,326,002 | $12,831,377 | $16,339,215 | $16,591,226 |
| Investments | $19,825,522 | $23,128,749 | $26,272,088 | $26,302,745 | $27,222,657 |
| Receivables | $1,569,763 | $1,069,841 | $1,951,075 | $1,546,591 | $3,634,162 |
| Gross land, buildings, equipment (LBE) | $902,574 | $1,719,835 | $1,777,984 | $1,777,984 | $1,780,685 |
| Accumulated depreciation (as a % of LBE) | 70.2% | 1.3% | 11.3% | 22.2% | 32.3% |
| Liabilities (as a % of assets) | 35.3% | 34.7% | 32.0% | 38.3% | 49.0% |
| Unrestricted net assets | $23,435,957 | $23,746,085 | $21,729,371 | $21,393,752 | $30,540,884 |
| Temporarily restricted net assets | $585,075 | N/A | N/A | N/A | N/A |
| Permanently restricted net assets | $120,275 | N/A | N/A | N/A | N/A |
| Total restricted net assets | $705,350 | $607,317 | $10,264,495 | $9,360,102 | $5,148,266 |
| Total net assets | $24,141,307 | $24,353,402 | $31,993,866 | $30,753,854 | $35,689,150 |
Key data checks
| Key data checks info | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Material data errors | No | No | No | No | No |
Operations
The people, governance practices, and partners that make the organization tick.
Documents
Chief Executive Officer
Ms. Karen J. Collishaw MPP, CAE
Karen J. Collishaw, MPP, CAE, is Chief Executive Officer of the American Thoracic Society (ATS), a professional organization that comprises over 16,000 physicians, research scientists, nurses and other health professionals around the world with a mission in pulmonary (lung), critical care, and sleep medicine.
Prior to joining the ATS in May 2018, she was the President & CEO of the Community Health Accreditation Program (CHAP), an independent, not-for-profit accrediting body. Previously, Ms. Collishaw served in executive leadership positions with the American Academy of Dermatology and the American College of Cardiology (ACC).
After graduating from Cornell University, she worked in the U.S. House of Representatives and then in Battelle Memorial Institute’s Washington office. She earned a Master of Public Policy degree from Georgetown University, is a Certified Association Executive, and is Past President of the American Association of Medical Society Executives.
Number of employees
Source: IRS Form 990
American Thoracic Society, Inc.
Officers, directors, trustees, and key employeesSOURCE: IRS Form 990
Compensation data
American Thoracic Society, Inc.
Highest paid employeesSOURCE: IRS Form 990
Compensation data
American Thoracic Society, Inc.
Board of directorsas of 08/18/2024
Board of directors data
Dr. Irina Petrache, MD, ATSF
National Jewish Health
Term: 2024 - 2025
Irina Petrache, MD, ATSF
National Jewish Health
M. Patricia Rivera, MD, ATSF
University of North Carolina Chapel Hill
Raed Dweik, MD, MBA, ATSF
Cleveland Clinic
Jesse Roman, MD, ATSF
Jefferson Health
Donna Appell, RN
Hermansky Pudlak Syndrome Netowrk
Alison K. Bauer, PhD, ATSF
Colorado School of Public Health
Debra M. Boyer, MD, MPHE
Nationwide Children's Hospital
Vinicio A. de Jesus Perez, MD, FCCP, FAHA, ATSF
Stanford University
Rachael Evans, MBChB, FRCP, PhD
University of Leicester
C. Terri Hough, MD, MSc, ATSF
Oregon Health and Science University
Terri A. Laguna, MD, Msci, ATSF
Seattle Children's Hospital
Robert L. Owens, MD, ATSF
University of California - San Diego
Angela Rogers, MD, MPH, ATSF
Stanford University
Christopher G. Slatore, MD, MS
Portland VA Medical Center
Tisha Wang, MD, ATSF
University of California - Los Angeles
Sarah Beesley, MD, MSc
Intermountain Health
Margaret Ann Carno, PhD, MBA, RN, CPNP, ATSF
University of Rochester
Mark Cohen-Todd, MD
Guatemala
Michelle Gong, MD, MS
Monte Fiore Medical Center
Ravi Kalhan, MD, MS
Northwestern University
Hasmeena Kathuria, MD, ATSF
University of Wisconsin
Jason P. Kirkness, PhD, ATSF
University of Miami
Kenneth Olivier, MD, MPH, ATSF
University of North Carolina
Valerie Press, MD, MPH, ATSF
University of Chicago
Elizabeth Redente, PhD, ATSF
National Jewish Health
Jason Woods, PhD, ATSF
Cincinnati Children's Hospital
Gregory Tino, MD, ATSF, FCCP, FACP
Observer - Penn Presbyterian Medical Center
Lynn M. Schnapp, MD, ATSF
Observer - University of Wisconsin
Board leadership practices
GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.
-
Board orientation and education
Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes -
CEO oversight
Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes -
Ethics and transparency
Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes -
Board composition
Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes -
Board performance
Has the board conducted a formal, written self-assessment of its performance within the past three years? Yes
Organizational demographics
Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.
Leadership
The organization's leader identifies as:
Race & ethnicity
Gender identity
Transgender Identity
Sexual orientation
No data
Disability
No data
Equity strategies
Last updated: 08/05/2024GuideStar partnered with Equity in the Center - an organization that works to shift mindsets, practices, and systems to increase racial equity - to create this section. Learn more
- We ask team members to identify racial disparities in their programs and / or portfolios.
- We seek individuals from various race backgrounds for board and executive director/CEO positions within our organization.
- We have community representation at the board level, either on the board itself or through a community advisory board.
- We help senior leadership understand how to be inclusive leaders with learning approaches that emphasize reflection, iteration, and adaptability.
- We engage everyone, from the board to staff levels of the organization, in race equity work and ensure that individuals understand their roles in creating culture such that one’s race identity has no influence on how they fare within the organization.
Contractors
Fiscal year endingGuideStar Pro Reports
Report successfully added to your cart!
Want more data?
A GuideStar Pro report containing the following information is available for this organization:
- Email contact information
- Financial trends metrics for five most recent years 2022, 2021, 2020, 2019, 2018*
- Financial statements for 2022
- Letter of Determination
- Officer and/or Employee data for 2022, 2021, 2020, 2019, 2018
- Contractor and/or Paid Preparer data for 2022, 2021, 2020
- Board of Directors data for 2024
- *with the ability to download the data for 2022, 2021, 2020, 2019, 2018
Download it now for $125.
Need the ability to download nonprofit data and more advanced search options?Consider a Pro Search subscription.